Free Trial
NASDAQ:TELA

TELA Bio (TELA) Stock Price, News & Analysis

TELA Bio logo
$2.08 +0.17 (+8.64%)
As of 07/3/2025 01:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About TELA Bio Stock (NASDAQ:TELA)

Key Stats

Today's Range
$1.95
$2.09
50-Day Range
$0.94
$2.08
52-Week Range
$0.86
$5.18
Volume
21,868 shs
Average Volume
214,709 shs
Market Capitalization
$82.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.25
Consensus Rating
Moderate Buy

Company Overview

TELA Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

TELA MarketRank™: 

TELA Bio scored higher than 52% of companies evaluated by MarketBeat, and ranked 513th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    TELA Bio has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    TELA Bio has received no research coverage in the past 90 days.

  • Read more about TELA Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for TELA Bio are expected to grow in the coming year, from ($1.37) to ($0.66) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of TELA Bio is -1.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of TELA Bio is -1.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    TELA Bio has a P/B Ratio of 2.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about TELA Bio's valuation and earnings.
  • Percentage of Shares Shorted

    1.51% of the float of TELA Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    TELA Bio has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TELA Bio has recently decreased by 12.97%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    TELA Bio does not currently pay a dividend.

  • Dividend Growth

    TELA Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.51% of the float of TELA Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    TELA Bio has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TELA Bio has recently decreased by 12.97%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for TELA Bio this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, TELA Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.70% of the stock of TELA Bio is held by insiders.

  • Percentage Held by Institutions

    94.35% of the stock of TELA Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about TELA Bio's insider trading history.
Receive TELA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TELA Bio and its competitors with MarketBeat's FREE daily newsletter.

TELA Stock News Headlines

Breakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

TELA Stock Analysis - Frequently Asked Questions

TELA Bio's stock was trading at $3.02 at the beginning of the year. Since then, TELA shares have decreased by 31.3% and is now trading at $2.0750.

TELA Bio, Inc. (NASDAQ:TELA) posted its quarterly earnings data on Thursday, May, 8th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.04. The company had revenue of $18.52 million for the quarter, compared to analyst estimates of $17.35 million. TELA Bio had a negative trailing twelve-month return on equity of 402.45% and a negative net margin of 61.00%.
Read the conference call transcript
.

TELA Bio (TELA) raised $60 million in an initial public offering on Friday, November 8th 2019. The company issued 4,000,000 shares at $14.00-$16.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Shares of TELA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TELA Bio investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Chevron (CVX).

Company Calendar

Last Earnings
5/08/2025
Today
7/06/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TELA
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.25
High Stock Price Target
$12.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+249.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.84 million
Pretax Margin
-61.13%

Debt

Sales & Book Value

Annual Sales
$69.30 million
Price / Cash Flow
N/A
Book Value
$0.72 per share
Price / Book
2.88

Miscellaneous

Free Float
37,696,000
Market Cap
$82.09 million
Optionable
Optionable
Beta
0.90
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:TELA) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners